Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Acquisitions (2024 - 2025)

Rxo (RXO) has disclosed Acquisitions for 2 consecutive years, with $10.0 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Acquisitions changed N/A year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Dec 2025, down 99.02%, and an annual FY2025 reading of $10.0 million, down 99.02% over the prior year.
  • Acquisitions was $10.0 million for Q1 2025 at Rxo, down from $1.0 billion in the prior quarter.
  • Across five years, Acquisitions topped out at $1.0 billion in Q3 2024 and bottomed at $10.0 million in Q1 2025.